| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |